AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 4006263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31306399 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated quadrivalent influenza vaccine (IIV4)
Number of subjects: 12018
Study 31306399 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12018
Study 29543568 — intervention group
Group type: EXPERIMENTAL
Intervention: PBL health literacy program
Number of subjects: 0
Study 29543568 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 0
Study 27576846 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM2 inhibitor SAR405838
Number of subjects: 0
Study 25065489 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine pharmacotherapy and behavioral treatment
Number of subjects: 179
Study 23751902 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared care model with one tertiary appointment followed by up to 11 general practice consultations over one year, supported by web-based software.
Number of subjects: 118
Study 23751902 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 118
Study 20151996 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate Mediterranean diet (LCM)
Number of subjects: 259
Study 20151996 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet (TM)
Number of subjects: 259
Study 20151996 — intervention group
Group type: EXPERIMENTAL
Intervention: 2003 American Diabetic Association diet (ADA)
Number of subjects: 259
Study 20151996 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 259
Study 17957000 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CrM) supplementation (loading phase, 20 g/day x 3 days; maintenance phase, 5 g/day x 7 days)
Number of subjects: 12
Study 17957000 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CrM) supplementation
Number of subjects: 12
Study 15685069 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful osteoarthritis of the knees
Number of subjects: 17
Study 15685069 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 17
Study 12855261 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) and folinic acid (FUFA) plus gemcitabine (GEM)
Number of subjects: 0
Study 12855261 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) and folinic acid (FUFA)
Number of subjects: 0
Study 10624435 — intervention group
Group type: EXPERIMENTAL
Intervention: MTI photoscreener
Number of subjects: 38
Study 10624435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycloplegic refraction
Number of subjects: 38
Study 7731108 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant growth hormone (r‐hGH) at a dose of 0.5 IU/kg/week
Number of subjects: 27
Study 7731108 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant growth hormone (r‐hGH) at a dose of 1.0 IU/kg/week
Number of subjects: 27
Study 2289410 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600mg twice daily
Number of subjects: 4081
Study 2289410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4081
Study 6172073 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextranomer (Debrisan)
Number of subjects: 84
Study 6172073 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase-streptodornase (Varidase)
Number of subjects: 84
Study 31152468 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (BMI > 28 kg/m2)
Number of subjects: 122
Study 31152468 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal BMI)
Number of subjects: 122
Study 31152468 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI, adiponectin, and leptin
Number of subjects: 122
Study 28152330 — intervention group
Group type: EXPERIMENTAL
Intervention: Early KMC
Number of subjects: 160
Study 28152330 — intervention group
Group type: COMPARATOR
Intervention: Late KMC
Number of subjects: 160
Study 24916951 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month exercise intervention (160 min/week of moderate intensity aerobic walking, twice weekly resistance training with resistance bands, and six discussion groups)
Number of subjects: 46
Study 24916951 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month exercise intervention
Number of subjects: 46
Study 24916951 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 24370303 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrandrine (100 mg) twice a day + Acetylcysteine effervescent tablets (600 mg) twice a day
Number of subjects: 96
Study 24370303 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy (anti-inflammatory, antitussive, and antiasthmatic drugs)
Number of subjects: 96
Study 21385365 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy plus standard wound care
Number of subjects: 118
Study 21385365 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care only
Number of subjects: 118
Study 19290718 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 172
Study 19290718 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 172
Study 16815864 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous treatment with celecoxib 200 mg once daily
Number of subjects: 123
Study 16815864 — intervention group
Group type: COMPARATOR
Intervention: Intermittent treatment with celecoxib 200 mg once daily
Number of subjects: 123
Study 15076811 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART
Number of subjects: 1431
Study 15076811 — intervention group
Group type: COMPARATOR
Intervention: ASMP
Number of subjects: 1431
Study 11889277 — intervention group
Group type: EXPERIMENTAL
Intervention: Safer Choices educational program
Number of subjects: 3869
Study 9624744 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic counselling (up to six 50-minute sessions)
Number of subjects: 162
Study 9624744 — intervention group
Group type: COMPARATOR
Intervention: Usual GP care
Number of subjects: 162
Study 8124176 — intervention group
Group type: EXPERIMENTAL
Intervention: Journeys to places to play outdoors (boys)
Number of subjects: 5334
Study 8124176 — intervention group
Group type: EXPERIMENTAL
Intervention: Trip to school (younger pupils aged 11-12)
Number of subjects: 5334
Study 8124176 — intervention group
Group type: EXPERIMENTAL
Intervention: Trip to school (poorer children)
Number of subjects: 5334
Study 8124176 — intervention group
Group type: EXPERIMENTAL
Intervention: Accompaniment by an adult (poorer children)
Number of subjects: 5334
Study 2682474 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 4 mg i.v.
Number of subjects: 47
Study 2682474 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 47
Study 911649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine 75 mg
Number of subjects: 0
Study 911649 — intervention group
Group type: COMPARATOR
Intervention: Desipramine 50 mg
Number of subjects: 0
Study 31160472 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional VR interactive game as a distraction
Number of subjects: 64
Study 27252077 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved Atta (IAtta) with nutritional and physical activity counseling
Number of subjects: 63
Study 27252077 — intervention group
Group type: COMPARATOR
Intervention: Control group with nutritional and physical activity counseling only
Number of subjects: 63
Study 26329916 — intervention group
Group type: EXPERIMENTAL
Intervention: UMEC/VI 62.5/25 µg
Number of subjects: 4647
Study 26329916 — intervention group
Group type: EXPERIMENTAL
Intervention: UMEC 62.5 µg
Number of subjects: 4647
Study 26329916 — intervention group
Group type: EXPERIMENTAL
Intervention: VI 25 µg
Number of subjects: 4647
Study 26329916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4647
Study 26329916 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS users
Number of subjects: 4647
Study 26329916 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ICS users
Number of subjects: 4647
Study 26329916 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs)
Number of subjects: 4647
Study 24135893 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg once daily
Number of subjects: 626
Study 24135893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 626
Study 22572567 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene gel used topically twice daily for 2 weeks
Number of subjects: 80
Study 22572567 — intervention group
Group type: COMPARATOR
Intervention: 2% ketoconazole cream used topically twice daily for 2 weeks
Number of subjects: 80
Study 19235039 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli intake (200 g)
Number of subjects: 20
Study 17518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR; 25% restriction)
Number of subjects: 48
Study 17518698 — intervention group
Group type: EXPERIMENTAL
Intervention: CR plus structured exercise (CR + EX)
Number of subjects: 48
Study 17518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD; 890 kcal/d diet until 15% weight loss)
Number of subjects: 48
Study 17518698 — intervention group
Group type: COMPARATOR
Intervention: Control (weight maintenance)
Number of subjects: 48
Study 15485530 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2) laser treatment
Number of subjects: 123
Study 15485530 — intervention group
Group type: COMPARATOR
Intervention: Glucantime treatment
Number of subjects: 123
Study 11466597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (screening and intervention program)
Number of subjects: 7042
Study 11466597 — intervention group
Group type: COMPARATOR
Intervention: Control group (risk screening, general advice)
Number of subjects: 7042
Study 11466597 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protocol analysis for both adults and children
Number of subjects: 7042
Study 9434650 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interviews
Number of subjects: 325
Study 9434650 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face interviews
Number of subjects: 325
Study 7988089 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (30 to 283 mg)
Number of subjects: 91
Study 2511610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol 20 mg thrice daily for 6 months
Number of subjects: 10
Study 2511610 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study 31351491 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine ear wash
Number of subjects: 280
Study 31351491 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cotrimoxazole
Number of subjects: 280
Study 31351491 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment (dry mopping and ciprofloxacin drops) plus dilute povidone-iodine ear wash
Number of subjects: 280
Study 31351491 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (dry mopping and ciprofloxacin drops) plus placebo
Number of subjects: 280
Study 28877043 — intervention group
Group type: EXPERIMENTAL
Intervention: One-legged exercise using one leg and both arms
Number of subjects: 28
Study 28877043 — intervention group
Group type: COMPARATOR
Intervention: Two-legged exercise using both legs and both arms
Number of subjects: 28
Study 26277270 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar disorder type II
Number of subjects: 33
Study 26277270 — intervention group
Group type: COMPARATOR
Intervention: Bipolar disorder type I
Number of subjects: 33
Study 24120480 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative FOLFOX4 chemotherapy (6 cycles of oxaliplatin 85mg/m², folinic acid 200 mg/m² or 100 mg/m², fluorouracil 400 mg/m² bolus and 600 mg/m² continuous infusion)
Number of subjects: 364
Study 24120480 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 364
Study 24120480 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative FOLFOX4 chemotherapy
Number of subjects: 364
Study 21145193 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MgSO(4) - 50mg of magnesium sulphate 5% (1.0 mL) added to 25 μg of fentanyl citrate (0.5 mL) and 300 μg of morphine
Number of subjects: 58
Study 21145193 — intervention group
Group type: COMPARATOR
Intervention: Control Group S - 25 μg of fentanyl citrate (0.5 mL) + 300 μg of morphine + 1.0 mL of preservative-free 0.9% sodium chloride
Number of subjects: 58
Study 21145193 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 18287358 — intervention group
Group type: EXPERIMENTAL
Intervention: CLA-rich fat (115 g/d, 5.5 g/d CLA oil, 39.4% cis9, trans11 and 38.5% trans10, cis12)
Number of subjects: 38
Study 18287358 — intervention group
Group type: COMPARATOR
Intervention: Control fat with a low content of CLA
Number of subjects: 38
Study 16510465 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary autologous bone marrow cell (BMC) transfer
Number of subjects: 59
Study 16510465 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 59
Study 12543892 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal haemoglobin (135-160 g/l)
Number of subjects: 416
Study 12543892 — intervention group
Group type: COMPARATOR
Intervention: Subnormal haemoglobin (90-120 g/l)
Number of subjects: 416
Study 10987585 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide (180 microg/kg bolus + continuous infusion of 2.0 microg/kg/min for ≤96 h)
Number of subjects: 9449
Study 10987585 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 9449
Study 10987585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9449
Study 9164283 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity strength training program
Number of subjects: 100
Study 9164283 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 100
Study 8011251 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentially antitoxoplasmic drugs (trimethoprim‐sulphamethoxazole, pyrimethamine, dapsone, pyrimethamine‐sulphadoxine, sulphadiazine)
Number of subjects: 499
Study 8011251 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic treatment
Number of subjects: 499
Study 2891797 — intervention group
Group type: EXPERIMENTAL
Intervention: VEPA-M (vincristine, cyclophosphamide, prednisolone, doxorubicin, and methotrexate)
Number of subjects: 163
Study 2891797 — intervention group
Group type: COMPARATOR
Intervention: VEPA (vincristine, cyclophosphamide, prednisolone, and doxorubicin)
Number of subjects: 163
Study 2891797 — intervention group
Group type: EXPERIMENTAL
Intervention: VEPA or VEPA-M therapy
Number of subjects: 163
Study 2891797 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting disease-free survival
Number of subjects: 163
Study 31735048 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient spiritual well‐being (FACIT‐SP Faith subscale)
Number of subjects: 175
Study 31735048 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient health‐related quality of life (PDQ‐39)
Number of subjects: 175
Study 31735048 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver depression (HADS Depression)
Number of subjects: 175
Study 31735048 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver anxiety (HADS Anxiety)
Number of subjects: 175
Study 31735048 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver perspective on patient quality of life (QOL‐AD Caregiver Perspective)
Number of subjects: 175
Study 30761565 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocurcumin
Number of subjects: 32
Study 30761565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 28091969 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental QoL scores (HADS-D)
Number of subjects: 400
Study 28091969 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental QoL scores (HADS-A)
Number of subjects: 400
Study 28091969 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental QoL scores (SF-36)
Number of subjects: 400
Study 28091969 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical QoL scores (SF-36)
Number of subjects: 400
Study 26600459 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment with ART for 12 months
Number of subjects: 113
Study 26600459 — intervention group
Group type: COMPARATOR
Intervention: Observation and deferred ART
Number of subjects: 113
Study 23219191 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging (DWI) in patients without chemoradiotherapy
Number of subjects: 21
Study 23219191 — intervention group
Group type: COMPARATOR
Intervention: Diffusion-weighted imaging (DWI) in patients after chemoradiotherapy
Number of subjects: 21
Study 23219191 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging (DWI) in adjacent rectum and fat
Number of subjects: 21
Study 20843978 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH eating pattern
Number of subjects: 31
Study 18430858 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal phonation CT during /hee/ phonation
Number of subjects: 31
Study 18430858 — intervention group
Group type: COMPARATOR
Intervention: Conventional axial CT
Number of subjects: 31
Study 16551140 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples intervention (n=28)
Number of subjects: 66
Study 16551140 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (n=38)
Number of subjects: 66
Study 16551140 — intervention group
Group type: COMPARATOR
Intervention: Comparable childless couples (n=13)
Number of subjects: 66
Study 12691976 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM) curriculum workshop series (ten sessions) introduced in 2000
Number of subjects: 0
Study 12691976 — intervention group
Group type: COMPARATOR
Intervention: Control group (residents at another FP residency at the same university)
Number of subjects: 0
Study 10871576 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 g protein/kg
Number of subjects: 8
Study 10871576 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g protein/kg
Number of subjects: 8
Study 10871576 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 g protein/kg
Number of subjects: 8
Study 10871576 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g protein/kg
Number of subjects: 8
Study 9107241 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular shunt
Number of subjects: 126
Study 9107241 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic treatment
Number of subjects: 126
Study 8256784 — intervention group
Group type: EXPERIMENTAL
Intervention: Live oral cholera vaccine CVD 103‐HgR (5 x 10(8) colony forming units)
Number of subjects: 0
Study 8256784 — intervention group
Group type: COMPARATOR
Intervention: Killed Escherichia coli K12 placebo
Number of subjects: 0
Study 3572463 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive consolidation chemotherapy (four courses)
Number of subjects: 0
Study 29292555 — intervention group
Group type: EXPERIMENTAL
Intervention: Klompas algorithm
Number of subjects: 66690
Study 29292555 — intervention group
Group type: COMPARATOR
Intervention: Majority of diabetes diagnosis codes being type 1
Number of subjects: 66690
Study 29292555 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine acetone test strips criterion
Number of subjects: 66690
Study 27634417 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Management intervention
Number of subjects: 2500
Study 27634417 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills Training intervention
Number of subjects: 2500
Study 27634417 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 2500
Study 27634417 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 2500
Study 23752057 — intervention group
Group type: COMPARATOR
Intervention: 18 mcg tiotropium
Number of subjects: 44
Study 23752057 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 mcg tiotropium plus 12 mcg formoterol
Number of subjects: 44
Study 23398256 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy media multitaskers
Number of subjects: 0
Study 23398256 — intervention group
Group type: COMPARATOR
Intervention: Light media multitaskers
Number of subjects: 0
Study 20825252 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 32 mg/kg
Number of subjects: 13
Study 20825252 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 64 mg/kg
Number of subjects: 13
Study 20825252 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 96 mg/kg
Number of subjects: 13
Study 20825252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 18279212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal flow-synchronized intermittent positive pressure ventilation (NFSIPPV)
Number of subjects: 63
Study 18279212 — intervention group
Group type: COMPARATOR
Intervention: Conventional nasal continuous positive airway pressure (NCPAP)
Number of subjects: 63
Study 16010547 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of 2 ml of sterile saline into the pack prior to opening
Number of subjects: 47
Study 16010547 — intervention group
Group type: COMPARATOR
Intervention: No injection of saline into the pack prior to opening
Number of subjects: 47
Study 12969670 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-wound suturing
Number of subjects: 20
Study 12969670 — intervention group
Group type: COMPARATOR
Intervention: Unaltered area of the defect (Control)
Number of subjects: 20
Study 10230828 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygiene program intervention
Number of subjects: 1729
Study 10230828 — intervention group
Group type: COMPARATOR
Intervention: Monitoring alone
Number of subjects: 1729
Study 10160446 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 units/kg
Number of subjects: 107
Study 10160446 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostasis Management System (HMS)
Number of subjects: 107
Study 10160446 — intervention group
Group type: EXPERIMENTAL
Intervention: RX/DX
Number of subjects: 107
Study 10160446 — intervention group
Group type: COMPARATOR
Intervention: Comparison of all methods
Number of subjects: 107
Study 1678392 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (100, 200, 500, 1000 micrograms)
Number of subjects: 7
Study 1678392 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical to salbutamol)
Number of subjects: 7